The integrated overview of the molecular mechanisms of HupA in AD showed the enhanced Wnt signaling, downregulation of the activity of GSK-3β, upregulation of Bcl-2 and neurotrophin, and downregulation of Bax (Friedli and Inestrosa, 2021). The gene discussed is GSK3B; the disease is Alzheimer disease.